#35
📈 Top 50
Rising voice in S&P 500 CEOs
AB

Albert Bourla

Pfizer
S&P 500 CEOs LinkedIn
#35
LinkedIn Rank
14,269
Benchmarker Score
0
Industry
11
Posts
11,674
Likes
865
Comments
1,061
Avg Likes
79
Avg Comments
12,539
Total Engagement
1,140
Engagement Rate
0.4
Posts/Week
Monthly
Posting Regularity
Metrics are based on tracked posts and calculated averages. Actual performance may vary.

Data last refreshed: February 10, 2026

Engagement metrics shown below reflect data as of this date. Current LinkedIn stats may differ.

Recent Posts

11 posts

This was a great conversation with Alyson Shontell. We reflected on the past few years, from the urgency of the COVID response to building for the long term. What energizes me most is the road ahea...

Strategic Vision & Direction Pharmaceuticals Long-term Vision R&D Investment CEO Perspective Jan 29, 2026 View on LinkedIn
284
Likes
14
Cmnts
7
Reposts

This was a remarkably productive week. I had the chance to speak with leaders from around the world, and this morning I joined a panel to help close the World Economic Forum Annual Meeting where ma...

Events & Speaking Engagements Artificial Intelligence Healthcare Pharmaceuticals Healthcare Policy R&D Investment Jan 26, 2026 View on LinkedIn
822
Likes
48
Cmnts
27
Reposts

Great to be back in Davos this week. Biopharma is at the center of the world's biggest questions: how we compete globally, how we harness AI and how we get breakthroughs to patients who need them m...

Events & Speaking Engagements Healthcare Pharmaceuticals Artificial Intelligence Industry Trends CEO Perspective Jan 26, 2026 View on LinkedIn
1,155
Likes
26
Cmnts
23
Reposts

In 2025, Pfizer proved once more that we know how to execute.At the J.P. Morgan Healthcare Conference hashtag#JPM2026, I shared the four strategic priorities guiding us in 2026:First, maximize the ...

Strategic Vision & Direction Corporate Strategy Mergers & Acquisitions R&D Investment Artificial Intelligence Pharmaceuticals Jan 19, 2026 View on LinkedIn
1,024
Likes
52
Cmnts
25
Reposts

Important comments from Steven Fulop, incoming CEO of Partnership for New York City. The new mayor's decision to revoke NYC's adoption of the International Holocaust Remembrance Alliance definition...

Policy & Regulatory Commentary Public Policy Government Relations Political Engagement Diversity & Inclusion Jan 12, 2026 View on LinkedIn
221
Likes
14
Cmnts
3
Reposts

Today we announced strong Q3 results, reflecting a pivotal moment for Pfizer. Our landmark U.S. Government agreement, proposed Metsera acquisition and continued R&D progress in oncology and across ...

Company Performance & Earnings Quarterly Earnings Mergers & Acquisitions Government Relations R&D Investment Pharmaceuticals Dec 02, 2025 View on LinkedIn
1,534
Likes
42
Cmnts
33
Reposts

Yesterday we celebrated Values Day at Pfizer. It brought me back to 2019 when I became CEO and we spent time thoughtfully defining our four values: Courage, Excellence, Equity and Joy. Every single...

Corporate Culture & Values Company Culture Employee Engagement CEO Perspective Purpose-Driven Business Nov 02, 2025 View on LinkedIn
1,264
Likes
30
Cmnts
11
Reposts

As the hostages in Gaza are returning home, I am filled with both gratitude and sorrow — and hope for what’s ahead. I am thankful to the American negotiators and our international partners whose ti...

Community & Philanthropy Geopolitics CEO Perspective Social Responsibility Nov 02, 2025 View on LinkedIn
1,115
Likes
52
Cmnts
23
Reposts

Incredible visit to our La Jolla site. This team has delivered real breakthroughs that are changing how we treat patients around the world.The site is entering a new chapter, and the energy I felt ...

Employee Recognition & Development Employee Recognition Company Culture Pharmaceuticals Nov 02, 2025 View on LinkedIn
828
Likes
11
Cmnts
6
Reposts

hashtag#BreakingNews: Today at the White House, we are proud to join President Trump to announce a landmark agreement that lowers drug costs for Americans while strengthening our nation’s role as t...

Policy & Regulatory Commentary Healthcare Policy Government Relations Public Policy Pharmaceuticals Oct 02, 2025 View on LinkedIn
2,547
Likes
515
Cmnts
175
Reposts

Earlier today, I issued a letter to our colleagues about another important step we are taking to prioritize focus, speed, and simplify our work processes. As we continue to deliver results, my dear...

Leadership & Executive Updates Organizational Design Change Management Executive Leadership C-Suite Operational Efficiency Aug 02, 2025 View on LinkedIn
880
Likes
61
Cmnts
3
Reposts

Rank History

No rank history yet

Content Categories

Events & Speaking Engagements 2
Policy & Regulatory Commentary 2
Strategic Vision & Direction 2
Company Performance & Earnings 1
Leadership & Executive Updates 1

Topics & Themes

Pharmaceuticals R&D Investment CEO Perspective Artificial Intelligence Government Relations Healthcare Healthcare Policy Mergers & Acquisitions Public Policy Company Culture Long-term Vision Industry Trends Corporate Strategy Political Engagement Diversity & Inclusion Quarterly Earnings Employee Engagement Purpose-Driven Business Geopolitics Social Responsibility

Top Quartile Benchmarks

Based on top 65 of 259 in S&P 500 CEOs

Posts
7
Albert: 11 ↑
Likes
7,081
Albert: 11,674 ↑
Comments
263
Albert: 865 ↑
Avg Likes
915.0
Albert: 1,061.3 ↑
Avg Comments
33.1
Albert: 78.6 ↑
Benchmarker Score
7,870
Albert: 14,269 ↑
Posts/Week
0.5
Albert: 0.4 ↓
Avg Post Length
679 chars
Albert: 978 ↑
Trending Topics (Top Quartile)
Artificial Intelligence Employee Recognition Company Culture Strategic Partnerships Customer Experience